台股 » 個股 » 智擎 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智擎

(4162)
可現股當沖
  • 股價
    100.5
  • 漲跌
    ▼3.0
  • 漲幅
    -2.90%
  • 成交量
    1,644
  • 產業
    上櫃 生技醫療類股
  • 309人加入追蹤

    立即追蹤

  • 本地時間:14:30

     
智擎 (4162)籌碼相關-兆豐-南京 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

兆豐-南京 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/03/285100.603101.17100.5021,7520.11%
2025/03/2500.005105.00104.50-51,719-0.29%
2025/03/2400.003106.00105.50-31,714-0.17%
2025/03/1900.001107.00104.50-11,718-0.06%
2025/03/170106.506106.00105.00-61,714-0.35%
2025/03/1400.001105.50105.00-11,713-0.06%
2025/03/131103.0000.00103.5011,7070.06%
2025/03/062111.5000.00111.0021,6470.12%
2025/02/273112.003109.50109.0001,5680.00%
2025/02/2600.0038117.43115.50-381,553-2.45%
2025/02/2100.001112.50113.00-11,412-0.07%
2025/02/2000.002111.00110.00-21,389-0.14%
2025/02/1900.0015110.00110.00-151,396-1.07%
2025/02/1800.0026109.13110.00-261,401-1.85%
2025/02/1700.004113.75112.50-41,397-0.29%
2025/02/1300.002111.25111.50-21,413-0.14%
2025/02/121112.004109.63112.00-31,408-0.21%
2025/02/119111.781112.00109.0081,3920.57%
2025/02/103118.5000.00118.5031,3370.22%
2025/02/071116.5000.00120.5011,3510.07%
2025/02/061117.504119.88119.00-31,329-0.23%
2025/02/052107.7510112.35113.00-81,194-0.67%
2025/02/04299.7000.00103.0021,2010.17%
2025/01/22196.1000.0096.1011,1930.08%
2025/01/20193.1000.0093.6011,2790.08%
2025/01/17193.2000.0093.2011,3640.07%
2025/01/16195.40195.6095.1001,3860.00%
2025/01/15493.8800.0093.1041,3800.29%
2025/01/09494.8000.0094.6041,3410.30%
2025/01/071101.001103.50101.5001,2750.00%
2025/01/0600.001101.50101.50-11,259-0.08%
2025/01/0300.00298.3098.30-21,240-0.16%
2025/01/02295.35295.5593.6001,2350.00%
2024/12/31190.3000.0090.3011,2230.08%
2024/12/30191.0000.0091.0011,2240.08%
2024/12/26291.6000.0092.5021,2250.16%
2024/12/20387.3300.0086.2031,2130.25%
2024/12/13288.5500.0088.8021,2090.17%
2024/12/10192.7000.0092.1011,1880.08%
2024/12/06193.7000.0093.3011,1800.08%
2024/12/02595.2600.0094.4051,1580.43%
2024/11/2900.00498.0097.50-41,136-0.35%
2024/11/28191.50192.7092.4001,1100.00%
2024/11/27895.4000.0094.1081,0950.73%
2024/11/26494.4800.0094.0041,0840.37%
2024/11/22595.0800.0093.8051,0310.48%
2024/11/21195.9000.0096.2011,0210.10%
2024/11/19195.8000.0096.0011,0150.10%
2024/11/18597.6200.0096.5051,0100.49%
2024/11/152100.2000.0099.9029890.20%
2024/11/144102.2500.00101.5049710.41%
2024/11/1300.005106.20106.50-5946-0.53%
2024/11/121100.501104.00104.0009160.00%
2024/11/111103.501104.50103.5008820.00%
2024/11/0800.001105.00103.00-1873-0.11%
2024/11/071103.007105.36103.50-6852-0.70%
2024/11/063104.171107.00102.5028260.24%
2024/11/0500.002107.25106.00-2782-0.26%
2024/11/044100.882101.00100.0027580.26%
2024/11/014107.255108.10105.00-1730-0.14%
2024/10/309102.3312102.21102.00-3617-0.49%
2024/10/292102.002101.50100.5006040.00%
2024/10/281102.008101.94102.00-7576-1.21%
2024/10/2500.00498.5097.40-4513-0.78%
2024/10/2400.00598.9098.30-5494-1.01%
2024/10/23193.80193.6093.7004240.00%
2024/10/17388.5300.0088.3034690.64%
2024/10/11388.8000.0088.3035020.60%
2024/10/09289.7000.0089.5025080.39%
2024/10/08189.80191.6091.1005070.00%
2024/10/07288.7500.0088.8025060.39%
2024/10/04388.5000.0088.7035410.55%
2024/10/01688.67189.8089.9055450.92%
2024/09/30789.5400.0089.5075501.27%
2024/09/25288.7000.0088.2026090.33%
2024/09/24389.2000.0090.2036120.49%
2024/09/23888.0800.0088.0086201.29%
2024/09/16183.0000.0082.7016410.16%
2024/09/13282.2500.0082.2026440.31%
2024/08/21187.60186.2086.6007460.00%
2024/08/1200.00084.0084.9007800.00%
2024/08/09086.0000.0085.4007830.00%
2024/08/0700.00186.1086.70-1794-0.13%
2024/08/05183.1000.0083.0017640.13%
2024/07/26195.10197.4097.6007290.00%
2024/07/22291.6000.0092.0027180.28%
2024/07/192095.6600.0094.20207082.82%
2024/07/02298.2500.0097.8026230.32%
2024/07/0100.00299.75101.00-2610-0.33%
2024/06/2600.00197.9097.60-1576-0.17%
2024/06/2500.00193.3094.30-1568-0.18%
2024/06/21196.1000.0093.7016070.16%
2024/06/20194.90194.2094.5006350.00%
2024/06/19194.6000.0093.8016370.16%
2024/06/14195.5000.0095.3016550.15%
2024/06/1300.00197.3096.90-1651-0.15%
2024/05/2400.00193.2092.80-1808-0.12%
2024/04/3000.00194.7093.70-11,425-0.07%
2024/04/2900.00395.1395.30-31,430-0.21%
2024/04/15394.2000.0094.1031,5650.19%
〈焦點股〉智擎胰腺癌新藥展望正向 股價帶量衝高Anue鉅亨-26天前
智擎胰腺癌新藥2024淨銷售額達標 5000萬美元授權金將入袋Anue鉅亨-2025/02/05
智擎 相關文章